Allschwil: New tenants on the BaseLink site

The BaseLink site in Allschwil is set to become "a new life science focal point", according to St.Gallen-based real estate company Senn. As a central component of the site development, Senn is realizing the Grid Campus of Collaboration with the architectural firm Herzog & de Meuron, with an area of around 50,000 sqm.

The Swizerland Innovation Park Basel Area will relocate its headquarters to the building, and companies and institutions of various sizes will also settle here. According to Senn, the target group includes start-ups, SMEs, research institutions and departments of major international corporations active in the healthcare and technology sectors.

At the end of June, the real estate company announced that the listed Basilea Pharmaceutical Ltd. and the University of Basel with its Department of Biomedical Engineering and the Innovation Office will move into the grid.

University of Basel rents 3,500 sqm in the Grid

The department will occupy a net area of around 3,500 square metres in the grid for research and teaching and will set up workplaces for 150 employees, plus around 100 students. About 1,700 sqm will be developed as technical research space with laboratories, workshops and for the technical infrastructure, 300 sqm are planned for lectures and seminars, Senn continued. Another 1,500 square meters will be used for offices, meeting rooms and a lounge.

The Innovation Office of the University of Basel will move into offices in the "Innovation Garage", which is located on the ground floor of the Parkhaus West in the immediate vicinity of the grid, at the beginning of 2021. The Innovation Garage was inspired by the innovative power of "garage companies" and designed as a low-threshold space. On 500 sqm there is an event room and collaboration offices. The Hortus beer garden is located right next to the parking garage.

Basilea moves headquarters to the Grid

The biotech company Basilea Pharmaceutica will move its headquarters to the Grid in mid-2022 and consolidate various locations in Basel there. According to Senn, Basilea wants to benefit from the proximity to innovative start-ups, academic institutions and other biotech companies. Basilea recently sold its main site at Grenzacherstrasse in Basel as part of a sale and leaseback transaction.

The landowner of the BaseLink site at Bachgraben in Allschwil is the Bürgerspital Basel. Senn is the building leaseholder for construction sites B1-B4 (Grid) and is also significantly involved in the development of other plots. On a total of 16 building plots, premises are being created for companies and institutions from the life science and biotech sectors. (ah)